{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:41:14Z","timestamp":1787010074326,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Targeted axillary dissection (TAD) after neoadjuvant therapy (NAT) includes the removal of both marked and sentinel lymph nodes (SLNs). The aim was to investigate the optimization of TAD localization techniques after NAT in breast cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      From November 2020 to 2022, the authors prospectively enrolled 107 lymph node-positive breast cancer patients at Shandong Cancer Hospital, all of them received complete cycles of NAT. Before treatment, patients were randomly divided into three groups: group A, marked node with clip (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =34); group B, marked node with\n                      <jats:sup>125<\/jats:sup>\n                      I seed (n=32); and group C, marked node with both a clip and\n                      <jats:sup>125<\/jats:sup>\n                      I seed (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =41). Dual tracers were used to search for SLNs after NAT. The primary endpoint was the detection rate of marked nodes and false-negative rate (FNR).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The detection rates using the TAD localization technique were 82.6% (28\/34), 100% (32\/32), and 100% (41\/41) for groups A, B, and C, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt;0.05). The FNR rates were 15.8%, 5.9%, and 5.6% among groups A, B, and C, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt;0.05). The FNR rates in cN1 patients were 5.1%, 2.7%, and 2.6%, among these three groups, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt;0.05). The change in distance between\n                      <jats:sup>125<\/jats:sup>\n                      I seeds and clips in axillary lymph nodes was &lt;3\u00a0mm. The FNR rates of TAD guided by dye tracers, radiolabeled tracers, and dual tracers were 5.4%, 5.2%, and 3.4%, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt;0.05). The negative predictive values were 93.0%, 93.0%, and 95.2%, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt;0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      Considering the inexpensive and high detection rate of\n                      <jats:sup>125<\/jats:sup>\n                      I seeds, it is recommended to use\n                      <jats:sup>125<\/jats:sup>\n                      I seeds for localizing metastatic nodes in neoadjuvant setting. The TAD guided by dye tracer is also a feasible option for axillary de-escalation surgery after NAT in countries or regions without access to radiolabeled colloid.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000002058","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T23:45:05Z","timestamp":1724370305000},"page":"529-535","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["The feasibility of targeted axillary dissection for breast cancer axillary surgery de-escalation after neoadjuvant therapy: a prospective cohort study"],"prefix":"10.1097","volume":"111","author":[{"given":"Qing-Da","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan"},{"name":"Department of Breast Surgery, Yantaishan Hospital of Yantai city, Yantai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Bi","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Guo","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Yantaishan Hospital of Yantai city, Yantai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-Bin","family":"Cong","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-wei","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan"},{"name":"Department of Breast Surgery, Taian Tumor Hospital, Taian, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Guang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan"},{"name":"Department of Breast Surgery, Taian Tumor Hospital, Taian, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Fei","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6252-684X","authenticated-orcid":false,"given":"Yong-Sheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1]]},"reference":[{"key":"R1-20260304","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/JS9.0000000000001099","article-title":"Exploration of immune checkpoint inhibitors in neoadjuvant therapy of early-stage breast cancer","volume":"110","author":"Ren","year":"2024","journal-title":"Int J Surg"},{"key":"R2-20260304","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jamaoncol.2024.0578","article-title":"Omission of axillary dissection following nodal downstaging with neoadjuvant chemotherapy","volume":"10","author":"Montagna","year":"2024","journal-title":"JAMA Oncol"},{"key":"R3-20260304","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"key":"R4-20260304","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","article-title":"Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis","volume":"269","author":"Simons","year":"2019","journal-title":"Ann Surg"},{"key":"R5-20260304","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"R6-20260304","doi-asserted-by":"crossref","first-page":"175","DOI":"10.6004\/jnccn.2024.0018","article-title":"Chronic Lymphocytic Leukemia\/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Wierda","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"R7-20260304","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"R8-20260304","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/S1470-2045(20)30739-7","article-title":"Indications for individual internal mammary node irradiation","volume":"22","author":"Qiu","year":"2021","journal-title":"Lancet Oncol"},{"key":"R9-20260304","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10549-012-2203-5","article-title":"A modified technology could significantly improve the visualization rate of the internal mammary sentinel lymph nodes in breast cancer patients","volume":"136","author":"Qiu","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"R10-20260304","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"R11-20260304","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"R12-20260304","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients","volume":"276","author":"Kuemmel","year":"2022","journal-title":"Ann Surg"},{"key":"R13-20260304","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3390\/cancers13071539","article-title":"The evolving role of marked lymph node biopsy (MLNB) and targeted axillary dissection (TAD) after neoadjuvant chemotherapy (NACT) for node-positive breast cancer: systematic review and pooled analysis","volume":"13","author":"Swarnkar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R14-20260304","first-page":"1863","article-title":"Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study","volume":"109","author":"Wu","year":"2023","journal-title":"Int J Surg"},{"key":"R15-20260304","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/bjs.7073","article-title":"Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer","volume":"97","author":"Straver","year":"2010","journal-title":"J Br Surg"},{"key":"R16-20260304","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.rxeng.2019.08.002","article-title":"Surgical clips vs. iodine-125 (125I) seeds for marking the location of nonpalpable malignant breast lesions: preliminary results","volume":"62","author":"Mendoza Arnau","year":"2020","journal-title":"Radiologia (Engl Ed)"},{"key":"R17-20260304","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.21037\/qims-22-824","article-title":"The efficacy and safety of 125I seeds combined with biliary stent placement versus stent placement alone for malignant biliary obstruction: a systematic review and meta-analysis","volume":"13","author":"Gao","year":"2023","journal-title":"Quant Imaging Med Surg"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:04:48Z","timestamp":1772625888000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002058","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"2024-07-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}